| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 128687 | 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) | 0.0278435641331422 | -0.17806061 |
| NSC 179074 | Lead, bis[(2-cyanoethyl)cyclohexylcarbamodithioato-S,S']-, (T-4)- | 0.0278435641331422 | -0.19895287 |
| NSC 236580 | .beta.-Alanine, N-[N-[N-[N-[1-(D-2-hydroxy-4-methyl-1-oxopentyl)-L-prolyl]-L-isoleucyl]-N-methyl-L-valyl]-N-methyl-L-alanyl]-, .rho.-lactone | 0.0278435641331422 | -0.19013297 |
| NSC 291926 | Null | 0.0278435641331422 | -0.19153706 |
| NSC 301477 | 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-4-O-methyl-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- | 0.0278435641331422 | 0.024358578 |
| NSC 328785 | ANTINEOPLASTIC-328785 | 0.0278435641331422 | -0.18500896 |
| NSC 359463 | Null | 0.0278435641331422 | -0.33081028 |
| NSC 605607 | Null | 0.0278435641331422 | -0.19137126 |
| NSC 607088 | Null | 0.0278435641331422 | -0.17597081 |
| NSC 610457 | Camptothecin Derivative | 0.0278435641331422 | 0.1142969 |